<SEC-DOCUMENT>0001628280-25-047224.txt : 20251029
<SEC-HEADER>0001628280-25-047224.hdr.sgml : 20251029
<ACCEPTANCE-DATETIME>20251029175949
ACCESSION NUMBER:		0001628280-25-047224
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251029
DATE AS OF CHANGE:		20251029

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BridgeBio Pharma, Inc.
		CENTRAL INDEX KEY:			0001743881
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-38959
		FILM NUMBER:		251431402

	BUSINESS ADDRESS:	
		STREET 1:		3160 PORTER DR.
		STREET 2:		SUITE 250
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		(650) 391-9740

	MAIL ADDRESS:	
		STREET 1:		3160 PORTER DR.
		STREET 2:		SUITE 250
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BridgeBio Pharma LLC
		DATE OF NAME CHANGE:	20180618

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCCORMICK FRANK
		CENTRAL INDEX KEY:			0001257809
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O UCSF, 1450 3RD STREET
		STREET 2:		RM HD-371
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			941439001
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <!-- Generated by Workiva -->
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001257809</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001743881</issuerCik>
      <issuerName>BridgeBio Pharma</issuerName>
      <secFileNumber>001-38959</secFileNumber>
      <issuerAddress>
        <com:street1>3160 Porter Drive</com:street1>
        <com:street2>Suite 250</com:street2>
        <com:city>Palo Alto</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94304</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>650-391-9740</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Frank McCormick</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Merrill Lynch</name>
        <address>
          <com:street1>555 California St, 18th Fl</com:street1>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94104</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>198359</noOfUnitsSold>
      <aggregateMarketValue>13206531.76</aggregateMarketValue>
      <noOfUnitsOutstanding>191168504</noOfUnitsOutstanding>
      <approxSaleDate>10/29/2025</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>10/01/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Bonus</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>BridgeBio Pharma</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>200000</amountOfSecuritiesAcquired>
      <paymentDate>10/01/2021</paymentDate>
      <natureOfPayment>Stock Bonus</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Frank McCormick</name>
        <address>
          <com:street1>3160 Porter Drive, Suite 250</com:street1>
          <com:city>Palo Alto</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94304</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>09/05/2025</saleDate>
      <amountOfSecuritiesSold>74000</amountOfSecuritiesSold>
      <grossProceeds>3932056</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Frank McCormick</name>
        <address>
          <com:street1>3160 Porter Drive, Suite 250</com:street1>
          <com:city>Palo Alto</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94304</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>10/27/2025</saleDate>
      <amountOfSecuritiesSold>1641</amountOfSecuritiesSold>
      <grossProceeds>106665</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>Shares sold under 10b5-1 plan</remarks>
    <noticeSignature>
      <noticeDate>10/29/2025</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>08/28/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>Frank McCormick</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
